Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Matorras, R.
Right arrow Articles by Rodríguez-Escudero, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matorras, R.
Right arrow Articles by Rodríguez-Escudero, F. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 17, No. 7, 1675, July 2002
© 2002 European Society of Human Reproduction and Embryology

Bye-bye urinary gonadotrophins?

The use of urinary gonadotrophins should be discouraged

Roberto Matorras,1 and Francisco J. Rodríguez-Escudero

Human Reproduction Unit, Hospital de Cruces, País Vasco University, Baracaldo, Vizcaya, Spain

In view of concerns regarding the potential presence and infectivity of prion proteins in human urinary gonadotrophin preparations, together with the availability of both recombinant FSH and recombinant LH, it is argued that the use of urinary gonadotrophins should be discouraged.

Key words: BSE/new variant CJD/TSE/urinary gonadotrophins

1 To whom correspondence should be addressed at: María Diaz de Haro 7, 6 iz, 48013 Bilbao, Spain. E-mail: rmatorras{at}hcru.osakidetza.net


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Endocr. Rev., April 1, 2006; 27(2): 170 - 207.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. W. Head, E. Kouverianou, L. Taylor, A. Green, and R. Knight
Evaluation of urinary PrPSc as a diagnostic test for sporadic, variant, and familial CJD
Neurology, May 24, 2005; 64(10): 1794 - 1796.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Matorras and F. J. Rodriguez-Escudero
Prions, urinary gonadotrophins and recombinant gonadotrophins
Hum. Reprod., May 1, 2003; 18(5): 1129 - 1130.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
C. Jansen
Bye-bye urinary gonadotrophins? Reply to Debate
Hum. Reprod., April 1, 2003; 18(4): 895 - 896.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
S.J. Dyer
Bye-bye urinary gonadotrophins?: The conflict between effective and affordable health care--a perspective from the developing world
Hum. Reprod., July 1, 2002; 17(7): 1680 - 1683.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.